Trade Teva Pharma Ind Adr Rep 1 - TEVA
Teva Pharmaceutical (TEVA) is a multinational pharmaceutical company set up in Jerusalem in 1901. The business’s primary focus is generic drugs. Teva is a world leader in specialty medicines. Teva production facilities are based in Israel, North America, South America and Europe. Their generic drugs portfolio includes over 1,000 products that represent therapeutic versions of innovative drugs. Their specialty medicines portfolio features a wide scope of treatments of the CNS disorders. The company’s shares are traded on the New York Stock Exchange (NYSE) and on the Tel Aviv Stock Exchange (TASE). To stay informed on the latest Teva Pharma share price, follow Capital.com.Latest shares articles

BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026

TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026

Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026

Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026
Related News